Perkin

Revvity, formerly the Life Sciences and Diagnostics business of PerkinElmer, is a global leader in providing health science solutions, technologies, and services. The company specializes in translational multi-omics technologies, biomarker identification, imaging, and automated laboratory solutions to accelerate drug discovery and development. Revvity's portfolio includes advanced diagnostics for reproductive health and oncology, as well as cutting-edge gene editing tools like the Pin-point base editing platform. By integrating high-throughput screening, preclinical imaging, and informatics, Revvity supports pharmaceutical and biotechnology companies in bringing novel therapies from the lab to the clinic.